IRIS

MAGGIO, ROBERTO

MAGGIO, ROBERTO  

Dipartimento di Scienze cliniche applicate e biotecnologiche  

Mostra records
Risultati 1 - 20 di 120 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterization 1-gen-1990 Del Zompo, M; Ruiu, S; Maggio, Roberto; Corsini, Gu
A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center 1-gen-2022 Carli, Marco; Risaliti, Eleonora; Francomano, Mena; Kolachalam, Shivakumar; Longoni, Biancamaria; Bocci, Guido; Maggio, Roberto; Scarselli, Marco
A quantitative analysis of antidepressant and antipsychotic prescriptions following an earthquake in Italy 1-gen-2011 Rossi, Alessandro; Maggio, Roberto; Riccardi, I; Allegrini, F; Stratta, P.
Affinity profiles at five cloned human muscarinic receptors (m1-m5) of a new series of antimuscarinic drugs. 1-gen-1993 Angeli, P; Gualtieri, F; Maggio, Roberto; Paparelli, F; Scapecchi, S.
Allosteric modulators of g protein-coupled dopamine and serotonin receptors: A new class of atypical antipsychotics 1-gen-2020 Fasciani, I.; Petragnano, F.; Aloisi, G.; Marampon, F.; Carli, M.; Scarselli, M.; Maggio, R.; Rossi, M.
An internal ribosome entry site (IRES), present within the third cytoplasmic loop, drives the expression of the Carboxyl-terminal domain of the human muscarinic M2 receptor 1-gen-2015 Maggio, Roberto; Fasciani, I; Di Gregorio, J; Flati, Vincenzo; Puca, V; Pietrantoni, I; Romeo, S.
An unusual form of the association binding kinetics of N-[3H]-methylscopolamine to the split muscarinic M2trunk/M2tail receptor 1-gen-2003 Novi, F; Scarselli, M; Corsini, Gu; Maggio, Roberto
Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor 1-gen-1998 Barbier, P.; Colelli, A.; Bolognesi, M. I.; Minarini, A.; Tumiatti, V.; Corsini, G. U.; Melchiorre, C.; Maggio, Roberto
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 1-gen-2020 Colapietro, A.; Gravina, G. L.; Petragnano, F.; Fasciani, I.; Scicchitano, B. M.; Beirinckx, F.; Pujuguet, P.; Saniere, L.; Van Der Aar, E.; Musio, D.; De Felice, F.; Mattei, V.; Martellucci, S.; Maggio, R.; Tombolini, V.; Festuccia, C.; Marampon, F.
Apomorphine continuous stimulation in Parkinson’s Disease: receptor desensitization as a possible mechanism of reduced motor response. 1-gen-1995 Maggio, Roberto; Barbier, P; Corsini, Gu
Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells. 1-gen-1999 Scarselli, M; Barbier, P; Salvadori, F; Armogida, M; Collecchi, P; Pardini, C; Vaglini, F; Maggio, Roberto; Corsini, Gu
Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate I 1-gen-2001 Chiarenza, A; Scarselli, M; Novi, F; Lempereur, L; Bernardini, R; Maggio, Roberto
Are olfactory receptors really olfactive? 1-gen-2011 Giorgi, F; Maggio, Roberto; Bruni, Le
The atypical antipsychotic clozapine selectively inhibits interleukin 8 (IL-8)-induced neutrophil chemotaxis. 1-gen-2015 Capannolo, Marta; Fasciani, Irene; Romeo, Stefania; Aloisi, Gabriella; Rossi, M; Bellio, Pierangelo; Celenza, Giuseppe; Cinque, Benedetta; Cifone, MARIA GRAZIA; Scarselli, M; Maggio, Roberto
Atypical antipsychotics and metabolic syndrome: From molecular mechanisms to clinical differences 1-gen-2021 Carli, M.; Kolachalam, S.; Longoni, B.; Pintaudi, A.; Baldini, M.; Aringhieri, S.; Fasciani, I.; Annibale, P.; Maggio, R.; Scarselli, M.
Binding profile of the selective muscarinic receptor antagonist tripitramine 1-gen-1994 Maggio, Roberto; Barbier, P; Bolognesi, Ml; Minarini, A; Tedeschi, D. AND MELCHIORRE C.
Blockade of GABA receptor in superior colliculus protects against focally-evoked limbic motor seizures 1-gen-1993 Gale, K; Pazos, A; Maggio, Roberto; Japikse, K; Pritchard, P.
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson’s disease epidemiology 1-gen-2013 Romeo, S; Viaggi, C; Di Camillo, D; Willis, Aw; Lozzi, Luca; Rocchi, C; Capannolo, M; Aloisi, G; Vaglini, F; Maccarone, Rita; Caleo, M; Missale, C; Racette, Ba; Corsini, Gu; Maggio, Roberto
The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT) 1-gen-2018 Rossi, M.; Taddei, A. R.; Fasciani, I.; Maggio, R.; Giorgi, F.
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 1-gen-2020 Petragnano, F.; Pietrantoni, I.; Camero, S.; Codenotti, S.; Milazzo, L.; Vulcano, F.; Macioce, G.; Giordani, I.; Tini, P.; Cheleschi, S.; Gravina, G. L.; Festuccia, C.; Rossetti, A.; Delle Monache, S.; Ordinelli, A.; Ciccarelli, C.; Mauro, A.; Barbara, B.; Antinozzi, C.; Schiavetti, A.; Maggio, R.; Di Luigi, L.; Polimeni, A.; Marchese, C.; Tombolini, V.; Fanzani, A.; Bernabo, N.; Megiorni, F.; Marampon, F.